- Home
- AHMA vs CNTX Comparison
AHMA vs CNTX Comparison
Compare AHMA & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AHMA | CNTX |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3M | 47.7M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AHMA | CNTX |
|---|---|---|
| Price | $1.24 | $0.28 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $4.03 |
| AVG Volume (30 Days) | 31.0K | ★ 963.0K |
| Earning Date | 11-22-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $180.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $0.29 |
| 52 Week High | $39.50 | $3.62 |
Technical Indicators
Market Signals| Indicator | AHMA | CNTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 29.65 |
| Support Level | $1.03 | N/A |
| Resistance Level | $1.51 | $0.36 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 14.27 | 4.29 |
Price Performance
Historical ComparisonAbout AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.